Susquehanna International Group’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,753
Closed -$7.49K 13555
2023
Q3
$7.49K Buy
+10,753
New +$6.97K ﹤0.01% 11749
2023
Q1
Sell
-16,833
Closed -$19.4K 13768
2022
Q4
$19.4K Sell
16,833
-13,379
-44% -$11K ﹤0.01% 11776
2022
Q3
$27K Sell
30,212
-53,900
-64% -$65.2K ﹤0.01% 12497
2022
Q2
$94K Buy
84,112
+45,375
+117% +$38.9K ﹤0.01% 11540
2022
Q1
$54K Sell
38,737
-422
-1% -$902 ﹤0.01% 12280
2021
Q4
$134K Sell
39,159
-49,218
-56% -$277K ﹤0.01% 11921
2021
Q3
$781K Buy
+88,377
New +$1.16M ﹤0.01% 8203

Other funds holding AFIB

Susquehanna International Group's AFIB Position: Q4 2023 in Review

Susquehanna International Group sold out of Acutus Medical Inc (AFIB) in Q4 2023, closing a stake of 10,753 shares — an estimated $7.49K sold.

Susquehanna International Group first reported a position in AFIB in Q3 2021 and held it in 7 quarters. The position peaked at $781K in Q3 2021. 29 funds tracked by Wall St. Rank hold AFIB as of Q4 2023.

  • Susquehanna International Group reported no remaining Acutus Medical Inc position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 10,753 Acutus Medical Inc shares in Q4 2023, an estimated $7.49K.
  • Susquehanna International Group first reported a position in Acutus Medical Inc in Q3 2021 and held it in 7 quarters.
  • Susquehanna International Group's Acutus Medical Inc position peaked at $781K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.